Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial

Overview of attention for article published in Vaccine, March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

twitter: 1 X user
patent: 8 patents

Readers on

mendeley: 95 Mendeley

So far, Altmetric has seen 8 patents that reference this research output.

Immunogenic compositions against Clostridioides (Clostridium) difficile and methods…

Grant US-12569547-B2

United States of America

10 Mar 2026

Vaccine for the prevention and treatment of C. difficile infections and the use thereof

Grant US-12194085-B2

United States of America

14 Jan 2025

Compositions and methods for eliciting an immune response against Clostridium difficile

Grant JP-7355490-B2

Japan

03 Oct 2023

PREDICTION OF CLINICAL MANIFESTATIONS OF GUT MICROBIOTA DYSBIOSIS

Application WO-2021123387-A1

World Intellectual Property Organisation (WIPO)

24 Jun 2021

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 4 additional patents.